Orthopediatrics (KIDS) Cash & Equivalents (2016 - 2026)

Orthopediatrics (KIDS) has 11 years of Cash & Equivalents data on file, last reported at $12.2 million in Q1 2026.

• On a quarterly basis, Cash & Equivalents fell 63.54% year-over-year to $12.2 million in Q1 2026; TTM through Mar 2026 was $12.2 million, a 63.54% decrease from a year earlier, with the FY2025 full-year figure at $19.6 million, down 55.37% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $12.2 million, down from $19.6 million in the prior quarter.
• Over the last five years, Cash & Equivalents for KIDS reached as high as $51.0 million in Q3 2024 and fell as low as $9.0 million in Q4 2022.
• Historically, Cash & Equivalents has averaged $26.4 million across 5 years, with a median of $25.3 million in 2024.
• Across the five-year window, Cash & Equivalents slumped 73.89% in 2023 and surged 379.77% in 2024, its largest moves.
• Year by year, Cash & Equivalents stood at $9.0 million in 2022, then soared by 245.4% to $31.1 million in 2023, then surged by 41.1% to $43.8 million in 2024, then slumped by 55.37% to $19.6 million in 2025, then slumped by 37.65% to $12.2 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $12.2 million in Q1 2026, $19.6 million in Q4 2025, and $16.8 million in Q3 2025.